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Background: The computational methods provide condition for investigation related to the process of drug
delivery, such as convection and diffusion of drug in extracellular matrices, drug extravasation from microvessels or
to lymphatic vessels. The information of this process clarifies the mechanisms of drug delivery from the injection
site to absorption by a solid tumor. In this study, an advanced numerical method is used to solve fluid flow and
solute transport equations simultaneously to investigate the effect of tumor shape and size on drug delivery to
solid tumor.
Methods: The advanced mathematical model used in our previous work is further developed by adding solute
transport equation to the governing equations. After applying appropriate boundary and initial conditions on
tumor and surrounding tissue geometry, the element-based finite volume method is used for solving governing
equations of drug delivery in solid tumor. Also, the effects of size and shape of tumor and some of tissue transport
parameters such as effective pressure and hydraulic conductivity on interstitial fluid flow and drug delivery are
investigated.
Results: Sensitivity analysis shows that drug delivery in prolate shape is significantly better than other tumor
shapes. Considering size effect, increasing tumor size decreases drug concentration in interstitial fluid. This study
shows that dependency of drug concentration in interstitial fluid to osmotic and intravascular pressure is negligible.
Conclusions: This study shows that among diffusion and convection mechanisms of drug transport, diffusion is
dominant in most different tumor shapes and sizes. In tumors in which the convection has considerable effect, the
drug concentration is larger than that of other tumors at the same time post injection.
Keywords: Drug concentration, Solid tumor, Tumor shape and size, Tissue transport propertiesBackground
Cancer, the main cause of death in developed countries,
is the second leading cause of death in developing coun-
tries [1]. Solid tumors account for 85% of human can-
cers [2]. Chemotherapy is one of the ways widely used
for cancer treatment. Based on the findings from clinical
applications, most cancer treatments with drugs fail to
eliminate solid tumors completely [3]. The computational
method can investigate why systemic administration
cannot distribute drug uniformly in tumors. The drug* Correspondence: msoltani@jhu.edu
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unless otherwise stated.exchange between microvessels and extracellular matrices,
drug removal by lymphatic system, drug diffusion and
convective transport in extracellular matrices should be
included by mathematical simulation. Computational fluid
dynamics (CFD) can model the whole drug delivery
process and clarify the mechanisms of drug delivery from
the injection site to absorption by a solid tumor.
Baxter and Jain, based on the theoretical framework
in their 1D mathematical method, found the effective
factors on drug delivery such as microvessel perme-
ability, interstitial fluid pressure (IFP), and interstitial
fluid velocity (IFV) [4-7].
Improving the 1D model of Baxter et al. [5,6,8] and
Saltzman et al. [9], Wang et al. [10-12] developed a
simulation framework of drug delivery to tumors byl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Interstitial transport properties used in numerical
simulations
Parameter Baseline value Reference
LP[cm/mmHg s]
Normal 0.36 × 10−7 [16]
Tumor 2.80 × 10−7
K[cm2/mmHg s]
Normal 8.53 × 10−9 [16]


















LPL SL/V [1/mmHg s]
Normal 1.33 × 10−5 [15]
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[10] used modified MRI images for tumor geometry.
They considered interstitial fluid flow with blood and
lymphatic drainage in their model. Wang et al. [11]
studied the effect of elevated interstitial pressure, con-
vective flux, and blood drainage on the delivery of speci-
fied solute to brain tumors.
The study of tissue transport property effect on drug
delivery is considered in recent studies. Zhao et al. [13]
used a 3D computational model to predict the distribu-
tion of IFV, IFP, and solute transport through a tumor.
Arifin et al. [14] studied the sensitivity of drug distribu-
tion to physiochemical properties in realistic models of
brain tumors. A specific tumor captured by MRI is used
by Pishko et al. [15] for modeling drug distribution in tis-
sue with spatially-varying porosity and vascular permeabil-
ity. The sensitivity of solute distribution to tumor shape
and size is not considered in above mentioned works.
In our previous work [2], tumor shape and size effect
on drug delivery is investigated by modeling interstitial
fluid flow and assuming that drug particles flow with the
interstitial fluid. In the present work, by adding the sol-
ute transport equation to the previous developed model
in our group [16-20], new governing equations are in-
vestigated to find drug concentration in interstitial fluid
(DCIF). Solving fluid flow and solute transport equa-
tions simultaneously, the effects of tumor shape, size,
and tissue transport properties on drug delivery to solid
tumor are also investigated.
Spherical and non-spherical tumors and their surroun-
ding normal tissue are modeled with assumption of rigid
porous media. The vasculature as a source term and
lymphatic vessel as a sink term vary spatially. In the fol-
lowing parts of this paper, the sensitivity analysis pro-
vides a better understanding of the effects of tissue
transport parameters on drug delivery.
Results
Simulation of interstitial fluid flow for baseline values
(Table 1) predicts that IFP has its greatest value in the
tumor center. IFP is non-dimensionalized by effective
pressure. The effective pressure, Peff, is a parameter de-
fined by intravascular pressure, plasma osmotic pressure,
and interstitial osmotic pressure by Equation (1). The
non-dimensionalized pressure is defined by Equation (2)
Peff ¼ PtB−σ ts πtB−πti
  ð1Þ








where t stands for tumor tissue. Parameters used in
Equation (1) and (2) are introduced in the method
section.Non-dimensionalized IFP along transverse and vertical
lines (shown in Figure 1), are illustrated in Figures 2 and
3. The maximum value of IFP occurs in the tumor cen-
ter (Figure 2). This value is equal to Peff, 1.53 kPa, except
for the case of λ = 0.1 (Prolate shape). IFP has uniform
distribution at tumor region and in the inner boundary
(for more detail see Figure 1 and boundary condition
section) IFP falls down sharply to around 150 Pa as
shown in Figure 2 for all shapes except for prolate one
(λ = 0.1). In normal tissue, pressure has uniform distri-
bution close to outer boundary (for more detail, see
Figure 1 and boundary condition section) then it decreases
smoothly to peripheral pressure. For prolate shape as
shown in Figure 2, IFP reduces smoothly from tumor
center to the outer boundary, and IFP has a non-zero
gradient in whole domain. Figure 2 shows the IFP along
vertical line. Results are very similar to IFP results in
Figure 2. Only for a prolate shape IFP has different pat-
tern from what is observed in Figure 2. Maximum value
of IFP in the prolate shape does not occur in the tumor
Figure 1 Schematic of considered geometry and boundary
conditions. The transverse and vertical lines are used to show
results along them.
Figure 3 Interstitial fluid pressure profile along vertical line.
The 1 in “x” axis shows the boundary of tumor (inner boundary).
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center and tumor periphery.
IFV distribution along the vertical and transverse lines
is presented in Figures 4 and 5. Maximum value of IFV
occurs close to the inner boundary. Also, in normal tis-
sue, IFV reaches zero far from the inner boundary. How-
ever, for the prolate shape, velocity is not zero, especially
along transvers line (Figure 4).
DCIF is simulated in two cases of injection. In the first
case, the continuous injection which leads to constant
plasma concentration (Cp = constant) is considered and
in the second case, the bolus injection in which the
plasma concentration decreases with time exponentially
(Cp ¼ C0pe− ln 0:5ð Þt=τ ) is studied, in which τ is the drug
half-life in plasma (Table 2). DCIF are non-dimensionalized
by CP for continuous injection and C
0
P for bolus injection,Figure 2 Interstitial fluid pressure profile along transverse line.
The 1 in “x” axis shows the boundary of tumor (inner boundary).respectively. Average of non-dimensionalized DCIF for
two injection cases in different times is shown in Figures 6
and 7. DCIF of prolate shape (λ = 0.1) has the maximum
value and DCIF of oblate shape (λ = 10) has the minimum
value. Other considered shapes show the similar transient
behavior.
Non-dimensionalized DCIF along two lines (transverse
and vertical) is illustrated in Figures 8 and 9. The bolus
injection results are presented in 8 hr post injection in
which the concentration is maximum based on Figure 7
and for continuous injection is presented at final time of
simulation, in 72 hr post injection. The profiles of two
types of injections are similar in spite of different values of
DCIF. As observed in IFV and IFP profiles, the prolateFigure 4 Interstitial fluid velocity profile along transverse line.
The 1 in “x” axis shows the boundary of tumor (inner boundary).
Figure 6 Average non-dimensionalized DCIF in tumor region in
during time for continuous injection.
Figure 5 Interstitial fluid velocity profile along vertical line. The
1 in “x” axis shows the boundary of tumor (inner boundary).
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tion. A bump is observed in DCIF curves at the inner
boundary of all tumor shapes. The normal tissue has uni-
form distribution of DCIF except near the boundaries
(inner and outer). DCIF distribution in normal tissue is
the same for all tumor shapes.
2D contours of DCIF in tumor region for bolus injection
in 8 hr post injection are shown in Figure 10 for all tumor
shapes. Results show that DCIF for tumors with λ = 0.1 and
λ = 10 has different distributions. Generally, in the inner
boundary, DCIF has its maximum value. In Figures 11 and
12, Peclet number distribution along two lines for con-
tinuous injection is shown. Peclet number demonstrates
the ratio of convection to diffusion across the microvesselTable 2 Parameters of solute transport model used in
numerical simulations






Normal 0.16× 10−12 [8]
Tumor 2.0× 10−12
P[m/s]




*- the microvessel permeability coefficient is 10% of effective permeability
introduced in [8].
**- the drug half-life in plasma introduced in results section.wall. Results show that in the tumor region Peclet
number is zero except for prolate shape. Peclet number
for the prolate shape especially along short radius
(transverse line) is greater than zero.
Some of tissue transport parameters mentioned (ef-
fective pressure, hydraulic conductivity, and tumor size)
in Table 1 are investigated for sensitivity analysis. The
values of these parameters are selected near the ranges
reported in the literature [2,15,21].
Figure 13 shows the influence of changing effective
pressure, Peff, on numerical results of tumor shapes with
the same volume. Maximum value of IFP in tumor region
(Figure 13a) linearly increases when Peff increases. Only inFigure 7 Average non-dimensionalized DCIF in tumor region in
during time for bolus injection.
Figure 8 Non-dimensionalized DCIF profile along transverse line for normal. Left for bolus injection and right for continuous injection. The
1 in “x” axis shows the boundary of tumor (inner boundary).
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tumor shapes. Average of IFV on inner boundary also
has the same pattern and linearly changes with Peff
(Figure 13b). The changes in average of DCIF in tumor
region for two cases of injection are shown in Figure 13c
and d. For these two cases of injection, the prolate shape
is more sensitive to Peff changes than other tumor shapes
and DCIF changes around 20% when the Peff changes from
500 Pa to 2500 Pa. The other shapes do not show signifi-
cant variations in DCIF for these ranges of Peff.
Different tumor sizes are studied with changes in their
volume. One of important metric of disease development
and response to tumor therapy with drug is volume of
tumors [22-25]. To quantify response to therapeutic reg-
imens and also assess disease progression, tumor volume is
used as a metric in many studies, such as Char et al. [26],
Jensen et al. [27] and Gass et al. [28].
As shown in Figure 14a, IFP has less value than Peff
when the tumor volume is smaller than 1 cm3. When the
tumor volume is in the order of 1 cm3, IFP reaches PeffFigure 9 Non-dimensionalized DCIF profile along vertical line. Left for
shows the boundary of tumor (inner boundary).and by increasing the tumor radius, IFP remains constant.
Average of IFV on the inner boundary generally decreases
with increasing tumor size, Figure 14b. Only in prolate
shape in small radii, IFV increases with the tumor size. As
shown in Figure 14c and d, the mean values of DCIF have
the greatest value in the smallest tumor. Also, the prolate
shape has the highest value of DCIF in all studied tumors.
Figure 15 shows the sensitivity of IFF parameters and
DCIF to hydraulic conductivity changes. Results show
that in all tumor shapes, if hydraulic conductivity in-
creases, the maximum value of IFP remains constant
and then decreases sharply. Average of IFV increases by
increasing hydraulic conductivity. DCIF increases by in-
creasing hydraulic conductivity and then reaches a con-
stant value in spite of increasing hydraulic conductivity.
Discussion
This study presents DCIF, IFP, and IFV in solid tumors
surrounded by normal tissue in two types of injection;
bolus and continuous one. The model used in this studybolus injection and right for continuous injection. The 1 in “x” axis
Figure 10 2D contour of DCIF in tumor region for bolus injection in 8 hr post injection for all tumor shapes.
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on concentration distribution; tumor shape and size.
Results of high IFP in tumors are discussed in our previ-
ous studies [2,16,17] and in the experimental results of Ari-
fin et al. [29] and Huber et al. [30]. Maximum value of IFP
in spherical tumors (1 cm radius) for baseline values in
Table 1 is 1529.5 Pa which is close to the studies of Jain et al.
[31], Chauhan et al. [32], and Arfin et al. [33]. The current
results are verified by experimental data of IFP measured
by Nielsen et al. [34]. In their work, the wick-in-needle
technique is used to measure IFP in two types of tumors
with the same volume as tumors in the current study. They
found IFP in the range of 1400 Pa to 1600 Pa.
IFV on tumor boundary in spherical tumors with base-
line values is around 0.05 μm/s which is at the same orderFigure 11 Peclet number (ratio of convection to diffusion
across the microvessel wall) along transverse line.of the prediction of Jain et al. [31] and experimental obser-
vation of Hompland et al. [35]. Also, the profile of drug
concentration for simulation with baseline values for
spherical tumor in different times (Figures 6 and 7) agrees
well with Baxter and Jain’s predictions [8]. Results show
that DCIF for prolate shape (λ = 0.1) always has the great-
est value. Results of transient DCIF (Figures 6 and 7) show
that drug delivery is much easier in the prolate tumors.
Also, the oblate shape (λ = 10) has the most resistance to
drug delivery. Following of this section, the reason of these
phenomena is investigated.
The uniform values of IFP for all tumor shapes except
prolate one (Figures 2 and 3) is equal to Peff. Non-uniform
IFP in prolate shape results in the maximum value ofFigure 12 Peclet number (ratio of convection to diffusion
across the microvessel wall) along vertical line.
Figure 13 The effect of different values of effective pressure on IFP, IFV and DCIF. a) The variation of maximum IFP in tumor region.
b) The variation of averaged IFV at tumor boundary. c) Average of DCIF in tumor region for continuous injection. d) Average of DCIF in tumor
region for bolus injection.
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Equation (17) is able to legitimize this behavior of tumor
shapes. The source term (the last term in the right hand
side of Equation (17)) includes diffusion and convection
terms. The convection term depends on the differences
between IFP and Peff based on starling’s law. This pressure
difference is close to zero (Figures 2 and 3) for all tumor
shapes except for the prolate one and therefore the con-
vection term only for prolate shape has non-zero value.
Because of the non-zero values of Peclet number for pro-
late shape in tumor region (Figures 11 and 12), the con-
centration for this shape is affected not only by diffusion
rate from vessels but also by convection rate from vessels.
The convection rate leads to higher level of DCIF in prolate
shape than that of other tumor shapes (Figures 6, 7, 8, 9
and 10). The non-zero values of Peclet number for prolate
shape are seen in an image based work of Zhao et al. as well
[13]. In normal tissue, Peclet number shows that drug de-
livery from microvessel to tissue is done by both mecha-
nisms of transfer, convection and diffusion.
The other effect of uniform pressure is zero pressure
gradients in all tumor shapes except for prolate one. Be-
cause of zero IFP gradient and based on Darcy’s equation,
IFV is close to zero in tumor tissue except for prolateshape. The close to zero value of IFV is predicted in a few
numerical studies such as Welter and Rieger [36]; Roy and
Riahi [37]; and experimental results of Hompland et al.
[35]. Zero IFV results in a negligible convection transport
(the second term of the right hand side of Equation (17))
and consequently the convection transport does not affect
drug distribution; and the diffusion transport (the first
term of the right hand side of Equation (17)) is the only
reason of drug transport in all tumor shapes except for
prolate one. Therefore, non-zero IFV in prolate shape, also
seen in Zhao et al. [13], is another reason of higher DCIF
values in this tumor shape with respect to other shapes.
The sharp pressure gradient (Figures 2 and 3) and
highest value of IFV (Figures 4 and 5) in the inner
boundary for all tumor shapes increases drug transport
and make a bump at this boundary for DCIF.
The sensitivity analysis of effective pressure shows that
the effective pressure does not have too much effect on
DCIF. In all tumor shapes, DCIF for a wide range of ef-
fective pressure changes smoothly; however, in prolate
shape, this change is sharper and increases by effective
pressure (Figure 13c and d). As mentioned, in the tumor
region for all tumor shapes except for prolate one the con-
vection rate, which depends on Peff, has a negligible role
Figure 14 The effect of different values of tumor size on IFP, IFV and DCIF. a) The variation of maximum IFP in tumor region. b) The
variation of averaged IFV at tumor boundary. c) Average of DCIF in tumor region for continuous injection. d) Average of DCIF in tumor region for
bolus injection.
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effect on drug concentration. However, in prolate shape,
increasing Peff increases pressure difference between IFP
and Peff and consequently the convection rate from vessels
in the tumor region; therefore, DCIF in prolate shape is
sensitive to Peff changes.
The tumor volume shows more effects on IFP, IFV, and
DCIF than other investigated parameters such as effective
pressure and hydraulic conductivity. The increasing tumor
volume increases significantly IFP (Figure 14a). The de-
pendency of IFP to tumor volume is observed in experi-
mental study of Gutmann et al. [38], Hompland et al. [39],
and Leguerney et al. [40], as well. When the tumor vol-
ume is in the order of 1 cm3, the sensitivity of IFP to
tumor size decreases. The independency of IFP to tumor
volume in in large tumors is observed in the study of
Leguerney et al. [40], as well. In their work, IFP changes
very slowly with tumor volume. Since the high IFP is in-
troduced as the main barrier of drug delivery to tumors,
IFP increasing with tumor volume leads to DCIF decrease
in these tumors. This reduction of DCIF with tumor size
is observed in Au et al. [41], as well. Since IFP reaches
around the effective pressure with increasing tumor vol-
ume, the convection rate is vanished and the diffusion ratereaches a constant value, and consequently the sensitivity
of DCIF to tumor size reduces. Lower IFP in the small
tumor sizes leads to increase the convection rate of source
term in Equation (17). Therefore, it is expected to have a
better drug distribution in small tumors.
Results show that IFV, IFP, and DCIF are sensitive to
tissue hydraulic conductivity changes. The hydraulic
conductivity is appeared only in Darcy’s law. This par-
ameter has a direct effect on IFF and indirect effect on
DCIF. Theoretical analysis shows that the PiPeff in tumor
region is proportional to 1− 1ﬃﬃ
κ




[8] (κ is hy-
draulic conductivity, see material section). In low values
of κ, the 1ﬃﬃ
κ




is negligible and Pi is close to Peff
(Figure 15a). Increasing κ, increases the 1ﬃﬃ
κ




and leads to sharp decrease in IFP. This dependency is
also observed by McCarty and Johnson [42]. For high
values of κ, IFP is very low and negligible in comparison
to Peff. IFP reduction from effective pressure increases
IFV around 5 times (Figure 15b). The hydraulic conduct-
ivity affects DCIF by convection rate from vessels (as
mentioned this value depends on difference between IFP
and Peff ). In low values of κ, since IFP is equal to Peff, the
Figure 15 The effect of different values of hydraulic conductivity on IFP, IFV and DCIF. a) The variation of maximum IFP in tumor region.
b) The variation of averaged IFV at tumor boundary. c) Average of DCIF in tumor region for continuous injection. d) Average of DCIF in tumor
region for bolus injection.
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mains constant. Increasing κ increases the convention
rate and consequently DCIF.
When hydraulic conductivity increases two to three or-
ders of magnitude, the mean values of DCIF are two times
greater than the average of DCIF for baseline values in
Table 1. However, after a specific value of hydraulic con-
ductivity, DCIF changes smoothly and reaches a constant
value because IFP is very low and convection rate only de-
pends on Peff.
Conclusions
A numerical approach which couples the mathematical
model of the lymphatic system and the interstitial flow
with the mathematical model of solute transport demon-
strates that DCIF is affected by two transport mecha-
nisms, convection and diffusion.
Drug convection and drug transport from microvessel
to tumor are blocked by high interstitial pressure (IFP)
which is uniformly distributed in most part of the
tumor. The large pressure gradient results in an out-
ward convective flow that washes out the drug extrava-
sated from microvessels at the tumor periphery. Thisstudy shows that when there is IFP gradient in the
tumor region instead of uniform IFP distribution which
occurs in some tumor shapes, DCIF is greater than that
of the uniform one.
As the effects of osmotic and intravascular pressure
on convection rate are negligible in most of tumor
shapes, the dependency of DCIF to these parameters is
very low.
The hydraulic conductivity which is another considered
parameter in sensitivity analysis has significant effect on
drug distribution since it increases the convection rate
from vessels.
Method
Mathematical model of interstitial fluid transport
This section introduces the mathematical model of
interstitial fluid transport in macroscopic scale [2,16].
Since normal and tumor tissue have characteristics the
same as porous media, fluid flow behavior is defined by
coupling the fluid flow governing equations. The mass
balance or continuity equation for steady state incom-
pressible fluid in the porous media with source and
sink of mass is [16]:
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where
vi: The interstitial fluid velocity,
ϕB: The source term, extravasation from microvessels,
and
ϕL: The drainage term, elimination by lymphatic system.
In biological tissues, the fluid source is evaluated through




PB−Pi−σ s πb−πið Þð Þ ð4Þ
where
Pi : Interstitial fluid pressure,
PB : Blood pressure in microvessel,
S
V : The surface area per unit volume of tissue for
transport in the interstitium,
πB: Microvessel oncotic pressure,
πi : Interstitial oncotic pressure,
Lp : The hydraulic conductivity of the microvessel wall,
and
σs: Osmotic reflection coefficient.
and the lymphatic system is related to the pressure dif-
ference between the interstitium and the lymphatic ves-
sels and is considered only for normal tissues [43]:
ϕL rð Þ ¼
LPLSL
V





ϕL: The volumetric flow rate into the lymphatic,
LPLSL
V : The lymphatic filtration coefficient, and
PL: The hydrostatic pressure of the lymphatic.
The momentum balance equation in its general form





















K: The permeability of the porous medium,
ρ : The density,
μ: The viscosity, and
F: The volume forces.
Since interstitial fluid is a Newtonian fluid and has low
velocity through the tissues, Equation (6) in the steady
state condition is simplified to Darcy’s law [16]:
∇Pi ¼ − μK
 
vi ð7Þ
The K/μ is defined as hydraulic conductivity of the in-
terstitium, κ:vi ¼ −κ∇Pi ð8Þ
Combination of momentum equation (Equation (8))
and the continuity equation (Equation (3)) results in
−∇⋅ κ∇Pið Þ ¼ ϕB−ϕL ð9Þ
When κ is constant, the interstitial pressure can be
expressed by
−κ∇2Pi ¼ ϕB−ϕL ð10Þ




PB−Pi−σ s πb−πið Þð Þ− LPLSLV Pi−PLð Þ Normal tissue
LPS
V





Molecular transport in tumors is based on the conserva-
tion laws for mass and momentum. The interstitial trans-
port of drug is governed by the convection diffusion
equation; therefore, the general equation for the mass bal-
ance of solutes can be written as:
∂C
∂t
¼ ∇⋅ Deff ⋅∇C
 
−∇⋅ viCð Þ þ ΦB−ΦLð Þ ð12Þ
where
C : The solute concentration based on tissue volume,
ΦB : The rate of solute transport per unit volume from
microvessel into the interstitial space,
ΦL : The rate of solute transport per unit volume from
the interstitial space into lymphatic vessels, and
Deff : The effective diffusion tensor.
For an isotropic and uniform diffusion in tissues, equation
(12) can be written as:
∂C
∂t
¼ Deff∇2C−∇⋅ vf C
 þ ΦB−ΦLð Þ ð13Þ
The solute transport rate across the lymphatic vessels
can be considered as [15]
ΦL ¼ ϕLC NormalTissue0 TumorTissue

ð14Þ
The solute transport rate across the microvessel can
be represented by Patlak equation [45]:
ΦB ¼ ϕB 1−σ f
 





Figure 16 Different shapes of solid tumors considered in this study. The five ellipsoid shapes changed from oblate to prolate are studied.
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ϕB: The fluid flow rate per unit volume of tissue
across the microvessel wall,
σf : The filtration reflection coefficient,
P : The microvessel permeability coefficient,
S/V : The microvessel surface area per unit volume of
tissue,
Cp : Solute concentration in the plasma.
By substituting Equations (15) and (14) in to
Equation (13):Figure 17 Algorithm of numerical simulation used for
calculating interstitial fluid flow parameter (IFV, IFP) and solute
transport parameter (DCIF).∂C
∂t
¼ Deff∇2C−∇⋅ vifCð Þ
þ ϕB 1−σ f
 















¼ Deff∇2C−∇⋅ vifCð Þ
þ ϕB 1−σ f
 
















A tumor surrounded by normal tissue is considered in this
study. The tumor shape is considered ellipsoid. A 2D sec-
tion of the geometry and boundaries are shown in Figure 1.
The three boundaries are indicated for geometry: a) the
center of tumor, b) the boundary between tumor and nor-
mal tissue, named inner boundary, c) the boundary at the
outer edge of geometry, named outer boundary. The
appropriate boundary conditions are implemented for
Equations (11) and (17). The no flux boundary condition
is applied at the center of the tumor; i.e. [16],
∇Pi ¼ 0 for r ¼ 0 ð18Þ
Deff∇C þ viC ¼ 0 for r ¼ 0 ð19Þ
The continuity of pressure and velocity for Equation
(11) and concentration and its flux for Equation (17) are
considered as appropriate boundary conditions for inner
boundary:
−κt∇PijΩ− ¼ −κn∇PijΩþ
PijΩ− ¼ PijΩþ ð20Þ
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where Ω− and Ω+ indicate the tumor and normal tissue
at the inner boundary.
For outer boundary, that the interstitial pressure is
constant; the Dirichlet type of boundary condition must
be applied [16]:
Pi ¼ for outer region ð22Þ
And for concentration, the open boundary condition is
used in the outer region [46]. The Open Boundary is
used to set up mass transport across boundaries where
both convective inflow and outflow can occur and de-
fined by Equation (23):
−n⋅∇C ¼ 0 ð23Þ
where n is the normal vector.
Geometry
To investigate the effect of tumor shape on drug deliv-
ery, 5 different shapes are considered. The 3D funda-
mental shape of tumors is assumed to be an ellipsoid in
different studies. The assumption of considering ellips-
oid tumor shape is investigated in many research such
as breast cancer [47], prostate cancer [48,49] cervical
cancer [50], glioma cancer [51], and others [52]. Based
on this mentioned reason, ellipsoidal shapes of tumors
are considered in this study. Different shapes are pro-
duced by changing ratio of two radii of ellipsoid shown
in Figure 1. This ratio (λ = b/a) is changed from 0.1
(prolate) to 10 (oblate). In all shapes shown in Figure 16
the volume of the tumor is remained constant and equal
to the volume of spherical tumor with radius R. The
baseline value of R is 1 cm. The values of R used in sen-
sitivity analysis are changed from 0.1 cm to 2.5 cm. This
range is obtained from the literature and is close to the
experimental observations [40].
Model parameterization
The interstitial transport properties for normal and
tumor tissue are listed in Table 1. These values are used
as baseline and some of them are investigated and chan-
ged in specified ranges for sensitivity analysis.
The parameters of solute transport model taken from
Baxter and Jain [8] are listed in Table 2. Although, the nu-
merical model is applicable for any type of solute, in
present study the properties of Fragment antigen-binding
(F(ab’)2) as a sample is used.
Numerical solution
A systematic flow chart is illustrated in Figure 17 to clar-
ify the computational techniques involved in this paper.The criterion for the convergence of iterative solution
based on element–based finite volume (EB-FV) method
is to reduce the residual by 6 orders of magnitudes. The
details of numerical method is mentioned in our previ-
ous works [2,16,53].
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